Login / Signup

Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines.

Kefan SongSuzie H Pun
Published in: BME frontiers (2024)
With the recent advances in neoantigen identification, peptide-based cancer vaccines offer substantial potential in the field of immunotherapy. However, rapid clearance, low immunogenicity, and insufficient antigen-presenting cell (APC) uptake limit the efficacy of peptide-based cancer vaccines. This review explores the barriers hindering vaccine efficiency, highlights recent advancements in synthetic delivery systems, and features strategies for the key delivery steps of lymph node (LN) drainage, APC delivery, cross-presentation strategies, and adjuvant incorporation. This paper also discusses the design of preclinical studies evaluating vaccine efficiency, including vaccine administration routes and murine tumor models.
Keyphrases
  • papillary thyroid
  • lymph node
  • squamous cell
  • cell therapy
  • lymph node metastasis
  • case report
  • stem cells
  • neoadjuvant chemotherapy
  • risk assessment
  • childhood cancer
  • bone marrow
  • ultrasound guided
  • rectal cancer